ID:86
Study Name:GLIOFOCUS
Iras Number:1010468
Study Type:Interventional
Anatomical Region:Head and Neck
Disease Site:Brain
Study Status:Open
Site Location:
Clatterbridge Cancer Centre
65 Pembroke Place, Liverpool, L7 8YA
Full Study Title:
A Phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma
Research Summary:
Contact Information:
Date Site Open:
JUN
25
2025
Study End Date:
JAN
26
2028
Randomisation
Additional Appointments
Link to NIHR Database:
Not provided